Sns Financial Group, LLC Provention Bio, Inc. Transaction History

Sns Financial Group, LLC

  • $929 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$10.34 - $15.2 $191,703 - $281,808
-18,540 Closed
0 $0
Q1 2020

May 07, 2020
BUY
$5.42 - $17.75 $100,486 - $329,085
18,540 New
18,540 $171,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Sns Financial Group, LLC Portfolio

Follow Sns Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sns Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email